The effects of lowering LDL cholesterol with simvastatin plus ezetimibe in patients with chronic kidney disease (Study of Heart and Renal Protection): a randomised placebo-controlled trial-Reference-Cited by-同舟云学术

The effects of lowering LDL cholesterol with simvastatin plus ezetimibe in patients with chronic kidney disease (Study of Heart and Renal Protection): a randomised placebo-controlled trial

Published:2011-01 Issue: Volume:2011 Page:190-193
ISSN:0084-3873
Container-title:Yearbook of Medicine
language:en
Short-container-title:Yearbook of Medicine

Author:

Garrick R.

Publisher

Elsevier BV

Reference4 articles.

1. Efficacy and safety of cholesterol-lowering treatment: prospective meta-analysis of data from 90,056 participants in 14 randomised trials of statins;Baigent;Lancet,2005

2. Efficacy and safety of more intensive lowering of LDL cholesterol: a meta-analysis of data from 170,000 participants in 26 randomised trials;Baigent;Lancet,2010

3. FDA drug safety communication: new restrictions, contraindications, and those limitations for Zocor (simvastatin) to reduce the risk of muscle injury. US Department of Health and Human Services Food and Drug Administration; June 8, 2011.

4. The effects of lowering LDL cholesterol with simvastatin plus ezetimibe in patients with chronic kidney disease (Study of Heart and Renal Protection): a randomised placebo-controlled trial;Baigent;Lancet,2011

Cited by 38 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Comorbidity of patients with noncommunicable diseases in general practice. Eurasian guidelines;Cardiovascular Therapy and Prevention;2024-04-01

2. Lipoprotein dysfunction in patients with chronic kidney disease (CKD). Pathogenesis and treatment of CKD dyslipidemia (literature review);Nephrology (Saint-Petersburg);2024-03-03

3. Novel bioactive lipids enhanced HDL-mediated cholesterol efflux from macrophages through the ABCA1 receptor pathway;Chemistry and Physics of Lipids;2024-01

4. Treatment of ischemic heart disease in end-stage kidney disease patients on renal replacement therapy;Russian Journal of Transplantology and Artificial Organs;2023-11-13

5. 2023 China Guidelines for Lipid Management;Journal of Geriatric Cardiology;2023-09